ibi351,cetuximab,GFH925
innovent biologics,Zhejiang genfleet therapeutics,eli lilly
['ibi351', 'rectal', 'colorectal', '$ivbxf', 'innovent']
$ivbxf - innovent presents phase 1 clinical data of ibi351 (krasg12c inhibitor) as monotherapy for metastatic colorectal cancer at the 2023 asco annual meeting 
Follow for the latest #healthcare #stockmarket tweets. Visit https://t.co/wA5OfUn0Ee to try our powerful investing tools.